Follow us


NH TherAguix is a late-stage biotech company developing innovative nanomedicine that improve radiation therapy benefits without modifying current clinical workflows. Our leading product, AGuIX® is a nanoparticle designed to improve the localization of solid tumors and the outcomes of radiation therapy by a unique intravenous injection. The company is pursuing its strategy ambitiously as it is currently focused on its clinical development in the USA and on the preclinical development of a second generation drug.

Drug product manager

If you are interested in joining NH TherAguix, please contact us